Intratumoral mRNA/LNP Platform

About eTheRNA immunotherapies

eTheRNA immunotherapies is a platform-driven RNA-LNP technology company based in Niel, Belgium. It leverages decades of scientific expertise to offer integrated capabilities in RNA chemistry, LNP delivery technologies, and GMP manufacturing, supporting partners from discovery through clinical development. The company operates through a dual business model of technology/product partnering and is advancing its own clinical-stage pipeline, including an intratumoral oncology platform now in clinical testing with partner Almirall.

Therapeutic Areas

Other Non-melanoma skin cancer Drugs